Sanofi
SNY
SNY
674 hedge funds and large institutions have $14.5B invested in Sanofi in 2023 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 267 increasing their positions, 181 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 640 → 674 (+34)
0.71% more ownership
Funds ownership: 20.69% → 21.4% (+0.71%)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
Holders
674
Holding in Top 10
14
Calls
$116M
Puts
$75.5M
Top Buyers
| 1 | +$184M | |
| 2 | +$101M | |
| 3 | +$83.9M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$82.4M |
| 5 |
DC
Davenport & Co
Richmond,
Virginia
|
+$62.3M |
Top Sellers
| 1 | -$96.3M | |
| 2 | -$95.2M | |
| 3 | -$91M | |
| 4 |
JP Morgan Chase
New York
|
-$86.6M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$81.6M |